Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-round

September–October, 2018Volume 6, Issue 5, Pages 1758–1760.e1

Correspondence information about the author MD, PhD Hendrik Nolt

Email the author MD, PhD Hendrik Nolte

Hendrik Nolte, MD, PhD

David I. Bernstein, MD, FAAAAI

, 

Jörg Kleine-Tebbe, MD, FAAAAI

, 

Peter A. Fejerskov, RN, BSN

, 

Qing Li, PhD

, 

Susan Lu, PharmD

, 

Harrold S. Nelson, MD, FAAAAI

Open Access

PlumX Metrics

DOI: https://doi.org/10.1016/j.jaip.2017.12.035

Article Info

Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver Survey

September–October, 2018Volume 6, Issue 5, Pages 1559–1567

T. Ted Song, DOCorrespondence information about the author DO T. Ted SongEmail the author DO T. Ted Song

, 

Duncan Brown, PhD

, 

Martin Karjalainen, MD

, 

Ulrike Lehnigk, PhD

, 

Phil Lieberman, MD

Open Access

PlumX Metrics

DOI: https://doi.org/10.1016/j.jaip.2018.01.019

 |

Article Info

• Abstract

• Full Text
• Images
• References
• Supplemental Materials

Background

Anaphylaxis guidelines recommend prescription of more than 1 epinephrine autoinjector (EAI) for patients at risk. A second epinephrine dose is required in 16% to 36% of patients.

Prevalence of allergic sensitization, hay fever, eczema, and asthma in a longitudinal birth cohort

ORIGINAL RESEARCH

          

• Abstract
• Fulltext
• Metrics
• Get Permission

Authors Owens L, Laing IA, Zhang G, Turner S, Le Souëf PN

Received 9 April 2018

Accepted for publication 4 May 2018

Published 13 August 2018 Volume 2018:11 Pages 173—180

DOI https://doi.org/10.2147/JAA.S170285

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Luis Garcia-Marcos

Louisa Owens,^1,2 Ingrid A Laing,^3,4 Guicheng Zhang,^5,6 Stephen Turner,⁷ Peter N Le Souëf<sup>1

1</sup>School of Medicine, University of Western Australia, Perth, WA, Australia; ²School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW, Australia; ³Telethon Kids Institute, Perth, WA, Australia; ⁴School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia; ⁵School of Public Health, Curtin University, Perth, WA, Australia; ⁶Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, WA, Australia; ⁷School of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK

Effects of nasal dilator strips on subjective measures of sleep in subjects with chronic nocturnal nasal congestion: a randomized, placebo-controlled trial

Allergy, Asthma & Clinical Immunology

                 
• Research
• Open Access

• Eric J. SchenkelEmail author,
• Renee Ciesla and
• Gilbert Marava Shanga

Allergy, Asthma & Clinical Immunology201814:34

Abstract

Background

This exploratory study investigated effects of a new asymmetric butterfly-shaped prototype nasal dilator strip and the currently marketed clear Breathe Right Nasal Strip (BRNS) on subjective measures of nasal congestion and sleep quality.

The Role of Interleukin-19 in Contact Hypersensitivity.

Fujimoto Y, et al. Biol Pharm Bull. 2018.

Show full citation

Abstract

Interleukin (IL)-19 is a member of the IL-10 family of interleukins and is an immuno-modulatory cytokine produced by the main macrophages. The gastrointestinal tissues of IL-19 knockout mice show exacerbated experimental colitis mediated by the innate immune system and T cells.

Unintentional injection to the bone with a pediatric epinephrine auto-injector

• Allergy, Asthma & Clinical Immunology
• Case report
• Open Access

• Mariam Ibrahim and
• Harold KimEmail author

Allergy, Asthma & Clinical Immunology 2018 14:32

Abstract

Background

Skin-to-bone distance (STBD) in children prescribed a pediatric epinephrine auto-injector (EAI) for anaphylaxis is not commonly measured in practice. Recent evidence suggests that children with STBD less than the exposed needle length of available pediatric EAIs (dose: 0.15 mg, needle length: 12.7 mm) are at risk for unintentional injections to the bone during their use for an allergic emergency.

Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study

PLoS One. 2018 Aug 16;13(8):e0202078.

Lin Li, Ziliang Wang , Hong Liang, Fen Yang, Wei Yuan, Bizu Gelaye, Yongfu Yu, Maohua Miao , Mette Nørgaard, Jiong Li

Abstract

Background

Cerebral palsy (CP) is the most common physical developmental disability in childhood with a prevalence of 2 to 3 per 1000 live births. β2-adrenoreceptor agonist (β2AA) are widely used for the treatment of asthma. Maternal use of β2AAs may increase the risk of adverse neuro-psychiatric health outcomes in the offspring. No study, however, has evaluated the effect of prenatal exposure to β2AAs on the risk of CP.

Effectiveness of clarithromycin in patients with yellow nail syndrome

• Research article
• Open Access
• Open Peer Review

• Sachi Matsubayashi,
• Manabu SuzukiEmail authorView ORCID ID profile,
• Tomoyuki Suzuki,
• Ayako Shiozawa,
• Konomi Kobayashi,
• Satoru Ishii,
• Motoyasu Iikura,
• Shinyu Izumi,
• Koichiro Kudo and
• Haruhito Sugiyama

BMC Pulmonary Medicine201818:138

Open Peer Review reports

Abstract

Background

Yellow nail syndrome (YNS) is a rare disease characterized by the triad of thickened, slow-growing yellow nails, lymphedema, and chronic respiratory manifestations. The cause of YNS is not known; however, it is suggested to be due to a congenital lymph abnormality. Since YNS is accompanied by chronic bronchial infection in more than half of patients, we hypothesized that treatment with clarithromycin (CAM) could be effective.